Trial | NCT00329095  Report issue

Title

An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance
An Evaluation of Use of Topical Ocular Hypotensive Medication by Electronic Compliance Measures

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    latanoprost travoprost ...

  • Study Participants

    60
This is an open-label study in patients who are currently using either a topical prostaglandin as sole ocular hypotensive medical therapy q.d., or a topical prostaglandin plus an adjunctive topical ocular hypotensive marketed product either q.d., or b.i.d. in the same eye(s). Compliance will be measured over the two months of participation.
This is an open-label study in patients who are currently using either a topical prostaglandin as sole ocular hypotensive medical therapy q.d., or a topical prostaglandin plus an adjunctive topical ocular hypotensive marketed product either q.d., or b.i.d. in the same eye(s). Compliance will be measured over the two months of participation.
Study Started
Dec 31
2005
Study Completion
Apr 30
2006
Last Update
May 24
2006
Estimate

Drug travoprost, latanoprost, or bimatoprost

Drug Additional ocular hypotensive medication

Criteria 

Inclusion Criteria:

Currently using one or two topical ocular hypotensive medications

Exclusion Criteria:

Hypersensitivity to any component of medication
No Results Posted